What are the precautions for taking tucatinib/tucatinib?
Tucatinib/Tucatinib is an oral, small molecule HER2 tyrosine kinase inhibitor, mainly used as a combination treatment for HER2-positive breast cancer, especially in advanced or metastatic cases. Because of its strong targeting and relatively controllable side effects, this drug has gradually become an important supplement to HER2-targeted therapy in clinical practice. However, in order to ensure efficacy and safety, patients need to pay attention to several key issues when taking tucatinib.

First of all, the medication time and dosage of tucatinib must strictly follow the doctor's prescription, and you should not increase or decrease the dosage or stop the medication without authorization. The drug is usually taken twice daily and is not recommended on an empty stomach or with certain high-fat foods to avoid affecting its pharmacokinetics. In addition, drugs used in combination with tucatinib (such as capecitabine, trastuzumab) must also be managed according to the overall combination plan to avoid irregular administration of a single drug from affecting the overall treatment efficacy.
Secondly, tucatinib may cause side effects such as abnormal liver function, diarrhea, hand-foot syndrome, and fatigue. Liver function indicators should be checked regularly during treatment, especially changes in AST, ALT and bilirubin levels. If there is a significant increase, the dose should be adjusted or use should be suspended under the guidance of a doctor. For gastrointestinal symptoms such as diarrhea, patients should maintain good hydration and use antidiarrheal medications if necessary to control symptoms and avoid dehydration or electrolyte imbalance.
In addition, there are potential interactions between tucatinib and other drugs, especiallyInhibitors or inducers of the CYP3A enzyme metabolism pathway may significantly affect its plasma concentration. For example, certain antifungal, antiepileptic, or antiviral drugs may enhance or impair the metabolism of tucatinib, increasing the risk of toxicity or reducing efficacy. When taking other medications, you must inform your doctor in advance of all prescription drugs, over-the-counter drugs, herbal preparations, and nutritional supplements you use.
Reference materials:https://www.tukysa.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)